ERAS News & Events

The major averages closed slightly higher despite a continued stalemate in U.S.-Iran negotiations and continued disruption around the Strait of Hormuz. Markets begin the week in the green as they look to build on six straight weeks of gains, with investors trying to reconcile resilient economic data, rising geopolitical risk and an AI trade that refuses to cool off.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:FoxreportedCircle Internetreportedand provided FY26 guidanceDream Finders HomesBeazer Homesfor $25.75 per shareMosaicreported, lowered its FY26 CapEx guidance, and withdrew its FY26 phosphate production guidancePresident Trump is set to travel to China this week,including Tesla'sElon Musk and Apple'sTim Cook2. WALL STREET CALLS:UBSDell Technologieson valuation after rallyUberto Outperform at Fox Advisors as investments start paying offWendy'sto Underweight at JPMorganStarz Entertainmentto Outperform at BairdWall Streeton two recent IPOs, Madison Airand Arxis3. AROUND THE WEB:Starbucksplans to lay off 61 corporate staff in its technology unit at its Seattle headquarters, Reuters reportsApollo Globalis in talks to sell MidCap Financial, WSJ reportsA Microsoftdata center site in East Africa has been delayed due to disagreements with the Kenyan government over guaranteed payments, Bloomberg reportsGeneral Motorswill pay $12.75M to resolve a California investigation into claims that it illegally sold the location and driving data of OnStar subscribers to brokers, Reuters saysAppleis working on a "slight redesign" for macOS 27 to address Liquid Glass issues, Bloomberg says4. MOVERS:Babcock & Wilcoxrises afterMonday.comhigher afterand providing guidance for Q2 and FY26Erascagains after entering into anand supply agreement with MerckCertarafalls afterTelephone & Data Systemslower after Raymond Jamesthe stock to Market Perform from Outperform5. EARNINGS/GUIDANCE:Seadrillprovided areport for Q1Townsquare MediareportedDolereported ain Q1 earningsKodiak Gas Servicesprovided areport for Q1LiquidiareportedINDEXES:The Dow rose 95.31, or 0.19%, to 49,704.47, the Nasdaq gained 27.05, or 0.10%, to 26,274.13, and the S&P 500 advanced 13.91, or 0.19%, to 7,412.84.

"We continue to execute well across our RAS-targeting franchise, advancing ERAS-0015 clinical development ahead of schedule," said Jonathan Lim, Erasca's chairman, CEO, and co-founder. "The best-in-class potential of ERAS-0015 is striking, highlighted by robust responses in patients with KRAS G12X lung or pancreatic cancer, along with favorable safety and tolerability results primarily consisting of low-grade adverse events in our recently reported data. Notably, we believe ERAS-0015 has the potential to become a backbone of combination therapy based in part on the initial panitumumab combination data we shared last month. We continue to advance monotherapy expansion and combination dose escalation cohorts, with data from both anticipated in the first half of 2027."